ADMA
ADMA
US0008991046
ADMA Biologics Inc
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 510.173.000 426.454.000
19.6%
Cost of Revenue 217.408.000 206.901.000
5.1%
Gross Profit 292.765.000 219.553.000
33.3%
101.322.000 80.570.000
25.8%
Operating Income 191.443.000 138.983.000
37.7%
Pretax Income 182.656.000 125.714.000
45.3%
Net Income Common Stockholders 146.930.000 197.673.000
25.7%
-- --
--
-- --
--
ende